August J. Moretti - 24 Jun 2026 Form 4 Insider Report for Vivani Medical, Inc. (VANI)

Reporting relationship: Director
Issuer ticker: VANI
Reported as of: 24 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Jun 2026, 14:27:02 UTC
Prior SEC filing: 04 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Anthony Baldor, Attorney-in-fact

Key filing fact

August J. Moretti filed Form 4 for Vivani Medical, Inc. (VANI) on 26 Jun 2026.

Key facts

This page summarizes August J. Moretti's Form 4 filing for Vivani Medical, Inc. (VANI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 Jun 2026, 14:27.

Change

Previous filing in this sequence was filed on 04 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001344412 Primary reporting owner

Moretti August J

Relationship: Director
Address: C/O VIVANI MEDICAL, INC., 1350 S. LOOP ROAD, ALAMEDA
Signature: /s/ Anthony Baldor, Attorney-in-fact
Signature date: 26 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VANI transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value
Shares: +36,000
Change %
Price: $1.22^*
Shares after: 36,000
Date: 24 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 36,000
Exercise price: $1.22
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Initial grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.

Footnote F2

The option vests in monthly installments over the three-year period following the grant date, subject to continued service through such date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .